Skip to main content
Fig. 3 | Diabetology & Metabolic Syndrome

Fig. 3

From: Comparing angiotensin receptor–neprilysin inhibitors with sodium–glucose cotransporter 2 inhibitors for heart failure with diabetes mellitus

Fig. 3

Mean and standard error of systolic blood pressure (A), diastolic blood pressure (B), glycated hemoglobin (C), eGFR (D), and body weight (E) of follow-up measurements of patients undergoing ARNI versus SGLT2i treatment in the IPTW-adjusted cohort. ARNI angiotensin receptor–neprilysin inhibitor, IPTW inverse probability treatment weighting, SGLT2i sodium–glucose cotransporter 2 inhibitors

Back to article page

Diabetology & Metabolic Syndrome

ISSN: 1758-5996

Contact us